Treatment options for patients with glioblastoma multiforme (GBM), the most common form of malignant gliomas, now include anti-angiogenic therapy after failure of standard multi-modality treatments.
As such, Mustang plans to also request Orphan Drug Designation from the FDA for MB-101 (IL13Rα2‐targeted CAR-T cell therapy) in malignant gliomas. These advancements highlight our dedication to ...
Her research focuses on IDH-mutant gliomas, a class of brain tumors that are driven by mutations that regulate metabolism. She utilizes a combination of genetic, pharmacologic and metabolomic ...